RSV inhibiting 3-substituted quinoline and cinnoline derivatives

The invention concerns compounds of formula (I) having antiviral activity, in particular, having an inhibitory activity on the replication of the respiratory syncytial virus (RSV). The invention further concerns pharmaceutical compositions comprising these compounds and the compounds for use in the...

Full description

Saved in:
Bibliographic Details
Main Authors COOYMANS, Ludwig Paul, JONCKERS, Tim Hugo Maria, GUILLEMONT, Jérôme Émile Georges, RABOISSON, Pierre Jean-Marie Bernard, MC GOWAN, David Craig, GROSSE, Sandrine Céline, EMBRECHTS, Werner Constant Johan
Format Patent
LanguageEnglish
Published 05.01.2023
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The invention concerns compounds of formula (I) having antiviral activity, in particular, having an inhibitory activity on the replication of the respiratory syncytial virus (RSV). The invention further concerns pharmaceutical compositions comprising these compounds and the compounds for use in the treatment of respiratory syncytial virus infection.
Bibliography:Application Number: AU20210260799